Concepedia

Author

Zhengping Wang

Revolution Medicines (United States)ORCID

Also Known As

Der, Channing J., Jiang, Jingjing, Shifrin, Nataliya, WANG ZHENG-PING, Wang Zheng-Ping, Wang Zheng-ping, Wang ZhengPing, Wang Zhengping, ZHENGPING WANG, Zheng-Ping Wang

254

Publications

3.5K

Citations

31

H-Index

153

Concepts

All Affiliations

Revolution Medicines (United States)Liaocheng UniversityWomen's Hospital, School of Medicine, Zhejiang UniversityShandong UniversityGhent University
ZW

About

Zhengping Wang is an author at Revolution Medicines (United States) specializing in medicine, pharmacology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

19

1.1K

2

Engineering

10

10

182

3

Public Health

4

4

179

4

Natural Sciences

3

3

82

5

Health Sciences

2

2

49

Zhengping Wang

×

67

Publications

3.1K

Citations

30

H-Index

YearCitations

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers

Robert J. Nichols, Franziska Haderk, Carlos Stahlhut,

Nature Cell Biology

2018

407

Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy

Matthew Holderfield, Bianca J. Lee, Jingjing Jiang,

Nature

2024

268

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton,

Nature

2024

150

Clinical Pharmacokinetics, Metabolism, and Drug-Drug Interaction of Carfilzomib

Zhengping Wang, Jinfu Yang, Christopher J. Kirk,

Drug Metabolism and Disposition

2012

138

Pharmacokinetics, Pharmacodynamics, Metabolism, Distribution, and Excretion of Carfilzomib in Rats

Jinfu Yang, Zhengping Wang, Ying Fang,

Drug Metabolism and Disposition

2011

123

Alterations of serum resistin in normal pregnancy and pre-eclampsia

Danqing Chen, Minyue Dong, Fang Qin,

Clinical Science

2004

96

Effect of urease inhibitors on urea hydrolysis and ammonia volatilization

Zhengping Wang, Oswald Van Cleemput, Peter Demeyer,

Biology and Fertility of Soils

1991

95

Phase I Study of 30-Minute Infusion of Carfilzomib As Single Agent or in Combination With Low-Dose Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Kyriakos P. Papadopoulos, David S. Siegel, David H. Vesole,

Journal of Clinical Oncology

2014

95

A phase I/II study of carfilzomib 2–10-min infusion in patients with advanced solid tumors

Kyriakos P. Papadopoulos, Howard A. Burris, Michael S. Gordon,

Cancer Chemotherapy and Pharmacology

2013

84

Placental imbalance of Th1‐ and Th2‐type cytokines in preeclampsia

Minyue Dong, Jing He, Zhengping Wang,

Acta Obstetricia Et Gynecologica Scandinavica

2005

76

Page 1